Kasabach-Merritt Phenomenon: Diagnosis, Management, and Outcome on Two Cases in a Sub-Saharan Country (Senegal)

Introduction: Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case reports in dermatology Jg. 17; H. 1; S. 174 - 180
Hauptverfasser: Diop, Khadim, Ndiaye Diop, Mame Téné, Diop, Ibrahima, Mejri, Ines, Yassine, Lana, Diassé, Fatou, Tall, Fatime, Ba, Idrissa Demba, Ndiaye, Maodo, Ndiaye, Ousmane
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland S. Karger AG 21.04.2025
Schlagworte:
ISSN:1662-6567, 1662-6567
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Introduction: Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, particularly due to limited availability of treatment resources. We report 2 cases of KMP observed in a sub-Saharan Africa country (Dakar, Senegal). Case Presentation: Case 1: a 45-day-old male infant was admitted for a tumor lesion located in the axillary fold that has been evolving since birth. The lesion had rapidly become aggressive, inflammatory, and purpuric. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a kaposiform hemangioendothelioma complicated by a KMP was retained. Treatment with betamethasone was initiated, but death occurred 6 days later secondary to cerebral hemorrhage. Case 2: a 2-month-old female infant was admitted for a rapidly aggressive, inflammatory, infiltrating tumor lesion on the face that had been progressing for 1 month. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a KMP was retained. Treatment with corticosteroids, then combined with vincristine, was administered. The outcome was favorable with a considerable regression of the mass and improvement in biological parameters after 6 months. Conclusion: To our knowledge, we report the first case report on KMP in sub-Saharan Africa, particularly in pediatric dermatology in Dakar. Besides their rarity, these cases highlight the challenges in the management of KMP in a country with limited therapeutic resources.
AbstractList Introduction: Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, particularly due to limited availability of treatment resources. We report 2 cases of KMP observed in a sub-Saharan Africa country (Dakar, Senegal). Case Presentation: Case 1: a 45-day-old male infant was admitted for a tumor lesion located in the axillary fold that has been evolving since birth. The lesion had rapidly become aggressive, inflammatory, and purpuric. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a kaposiform hemangioendothelioma complicated by a KMP was retained. Treatment with betamethasone was initiated, but death occurred 6 days later secondary to cerebral hemorrhage. Case 2: a 2-month-old female infant was admitted for a rapidly aggressive, inflammatory, infiltrating tumor lesion on the face that had been progressing for 1 month. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a KMP was retained. Treatment with corticosteroids, then combined with vincristine, was administered. The outcome was favorable with a considerable regression of the mass and improvement in biological parameters after 6 months. Conclusion: To our knowledge, we report the first case report on KMP in sub-Saharan Africa, particularly in pediatric dermatology in Dakar. Besides their rarity, these cases highlight the challenges in the management of KMP in a country with limited therapeutic resources.
Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, particularly due to limited availability of treatment resources. We report 2 cases of KMP observed in a sub-Saharan Africa country (Dakar, Senegal).IntroductionKasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, particularly due to limited availability of treatment resources. We report 2 cases of KMP observed in a sub-Saharan Africa country (Dakar, Senegal).Case 1: a 45-day-old male infant was admitted for a tumor lesion located in the axillary fold that has been evolving since birth. The lesion had rapidly become aggressive, inflammatory, and purpuric. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a kaposiform hemangioendothelioma complicated by a KMP was retained. Treatment with betamethasone was initiated, but death occurred 6 days later secondary to cerebral hemorrhage. Case 2: a 2-month-old female infant was admitted for a rapidly aggressive, inflammatory, infiltrating tumor lesion on the face that had been progressing for 1 month. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a KMP was retained. Treatment with corticosteroids, then combined with vincristine, was administered. The outcome was favorable with a considerable regression of the mass and improvement in biological parameters after 6 months.Case PresentationCase 1: a 45-day-old male infant was admitted for a tumor lesion located in the axillary fold that has been evolving since birth. The lesion had rapidly become aggressive, inflammatory, and purpuric. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a kaposiform hemangioendothelioma complicated by a KMP was retained. Treatment with betamethasone was initiated, but death occurred 6 days later secondary to cerebral hemorrhage. Case 2: a 2-month-old female infant was admitted for a rapidly aggressive, inflammatory, infiltrating tumor lesion on the face that had been progressing for 1 month. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a KMP was retained. Treatment with corticosteroids, then combined with vincristine, was administered. The outcome was favorable with a considerable regression of the mass and improvement in biological parameters after 6 months.To our knowledge, we report the first case report on KMP in sub-Saharan Africa, particularly in pediatric dermatology in Dakar. Besides their rarity, these cases highlight the challenges in the management of KMP in a country with limited therapeutic resources.ConclusionTo our knowledge, we report the first case report on KMP in sub-Saharan Africa, particularly in pediatric dermatology in Dakar. Besides their rarity, these cases highlight the challenges in the management of KMP in a country with limited therapeutic resources.
Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy associated with vascular tumors. In sub-Saharan Africa, KMP-related data are scarce and it poses significant challenges in management, particularly due to limited availability of treatment resources. We report 2 cases of KMP observed in a sub-Saharan Africa country (Dakar, Senegal). Case 1: a 45-day-old male infant was admitted for a tumor lesion located in the axillary fold that has been evolving since birth. The lesion had rapidly become aggressive, inflammatory, and purpuric. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a kaposiform hemangioendothelioma complicated by a KMP was retained. Treatment with betamethasone was initiated, but death occurred 6 days later secondary to cerebral hemorrhage. Case 2: a 2-month-old female infant was admitted for a rapidly aggressive, inflammatory, infiltrating tumor lesion on the face that had been progressing for 1 month. Blood tests showed normocytic normochromic anemia with severe thrombocytopenia and high D-dimer levels. The diagnosis of a KMP was retained. Treatment with corticosteroids, then combined with vincristine, was administered. The outcome was favorable with a considerable regression of the mass and improvement in biological parameters after 6 months. To our knowledge, we report the first case report on KMP in sub-Saharan Africa, particularly in pediatric dermatology in Dakar. Besides their rarity, these cases highlight the challenges in the management of KMP in a country with limited therapeutic resources.
Author Tall, Fatime
Ndiaye, Maodo
Diop, Ibrahima
Ba, Idrissa Demba
Ndiaye Diop, Mame Téné
Mejri, Ines
Ndiaye, Ousmane
Diassé, Fatou
Diop, Khadim
Yassine, Lana
Author_xml – sequence: 1
  givenname: Khadim
  surname: Diop
  fullname: Diop, Khadim
– sequence: 2
  givenname: Mame Téné
  surname: Ndiaye Diop
  fullname: Ndiaye Diop, Mame Téné
– sequence: 3
  givenname: Ibrahima
  surname: Diop
  fullname: Diop, Ibrahima
– sequence: 4
  givenname: Ines
  surname: Mejri
  fullname: Mejri, Ines
– sequence: 5
  givenname: Lana
  surname: Yassine
  fullname: Yassine, Lana
– sequence: 6
  givenname: Fatou
  surname: Diassé
  fullname: Diassé, Fatou
– sequence: 7
  givenname: Fatime
  surname: Tall
  fullname: Tall, Fatime
– sequence: 8
  givenname: Idrissa Demba
  surname: Ba
  fullname: Ba, Idrissa Demba
– sequence: 9
  givenname: Maodo
  surname: Ndiaye
  fullname: Ndiaye, Maodo
– sequence: 10
  givenname: Ousmane
  surname: Ndiaye
  fullname: Ndiaye, Ousmane
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40438153$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtv1DAQxy1URB9w4AsgH1upgfEzDRdULQWqtirS7t2aJOPdoKxd7KSo375GLatyGM1o5qf_vA7ZXoiBGHsv4KMQpvkEAEZbkPCKHQhrZWWNrfdexPvsMOdfALYxVr1h-xq0OhNGHbB4hRlb7DbVDaU0TBP_uaEQt8XCZ_51wHWIecin_AYDrqnkp1OOoee389QVjMfAV38iX2CmzIfAkS_ntlriBhMGvohzmNIDP15SoDWOJ2_Za49jpnfP_oitvl2sFj-q69vvl4vz66qTRkHlfa9AmOJaL31vRWsMkkbvkRD7sq31pq1JAFnfAGotGyVrLbzSDUh1xL48yd7N7Zb6roydcHR3adhienARB_d_JQwbt473TkghGqhFUTh-Vkjx90x5ctshdzSOGCjO2SkplIWz2uqCfnjZbNfl35ULcPIEdCnmnMjvEAHu7wfd7oPqEeHUjQQ
Cites_doi 10.1186/s13023-020-1320-1
10.1007/s12519-020-00379-9
10.47391/JPMA.9185
10.3389/fped.2021.788120
10.3389/fped.2022.949950
10.3857/roj.2021.00983
10.1002/ccr3.7859
10.1016/j.jvs.2019.06.217
10.1002/pbc.30779
10.7499/j.issn.1008-8830.2103146
10.1007/s12098-021-03817-2
10.1136/bcr-2020-235065
10.1080/08880018.2023.2300485
10.3892/etm.2022.11558
10.1016/j.jpeds.2012.06.044
ContentType Journal Article
Copyright 2025 The Author(s). Published by S. Karger AG, Basel.
2025 The Author(s). Published by S. Karger AG, Basel 2025
Copyright_xml – notice: 2025 The Author(s). Published by S. Karger AG, Basel.
– notice: 2025 The Author(s). Published by S. Karger AG, Basel 2025
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1159/000546020
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Kasabach-Merritt Phenomenon
EISSN 1662-6567
EndPage 180
ExternalDocumentID PMC12119071
40438153
10_1159_000546020
Genre Journal Article
Case Reports
GroupedDBID ---
0~B
3O.
4.4
53G
5VS
6J9
7X7
8FI
8FJ
AAYXX
ABBTS
ABDBF
ABPAZ
ABUWG
ABWCG
ACGFS
ACUHS
ADBBV
AEGXH
AEYAO
AFKRA
AHFRZ
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E0A
EBS
F5P
FB.
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ITC
KQ8
M--
M~E
O5R
O5S
OK1
PHGZM
PQQKQ
PROAC
RNS
RPM
TR2
UKHRP
ADRAZ
ALIPV
C1A
CAG
COF
CYUIP
EJD
IPNFZ
M48
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c2530-ffd3015ffdbf2fd61b55ae4affaeaad5466f5b7e10e6f90a442932741f349023
ISSN 1662-6567
IngestDate Tue Sep 30 17:04:40 EDT 2025
Thu Oct 02 22:42:57 EDT 2025
Sun Jun 01 01:35:25 EDT 2025
Sat Nov 29 07:49:19 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Kasabach-Merritt phenomenon
Vascular tumors
Limited resources
Sub-Saharan Africa
Pediatric dermatology
Language English
License https://creativecommons.org/licenses/by-nc/4.0
2025 The Author(s). Published by S. Karger AG, Basel.
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2530-ffd3015ffdbf2fd61b55ae4affaeaad5466f5b7e10e6f90a442932741f349023
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
OpenAccessLink http://dx.doi.org/10.1159/000546020
PMID 40438153
PQID 3213608764
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12119071
proquest_miscellaneous_3213608764
pubmed_primary_40438153
crossref_primary_10_1159_000546020
PublicationCentury 2000
PublicationDate 2025-04-21
PublicationDateYYYYMMDD 2025-04-21
PublicationDate_xml – month: 04
  year: 2025
  text: 2025-04-21
  day: 21
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel, Switzerland
PublicationTitle Case reports in dermatology
PublicationTitleAlternate Case Rep Dermatol
PublicationYear 2025
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref8
  doi: 10.1186/s13023-020-1320-1
– ident: ref6
  doi: 10.1007/s12519-020-00379-9
– ident: ref9
  doi: 10.47391/JPMA.9185
– ident: ref12
  doi: 10.3389/fped.2021.788120
– ident: ref7
  doi: 10.3389/fped.2022.949950
– ident: ref4
  doi: 10.3857/roj.2021.00983
– ident: ref11
  doi: 10.1002/ccr3.7859
– ident: ref13
  doi: 10.1016/j.jvs.2019.06.217
– ident: ref14
  doi: 10.1002/pbc.30779
– ident: ref10
  doi: 10.7499/j.issn.1008-8830.2103146
– ident: ref2
  doi: 10.1007/s12098-021-03817-2
– ident: ref1
  doi: 10.1136/bcr-2020-235065
– ident: ref15
  doi: 10.1080/08880018.2023.2300485
– ident: ref5
  doi: 10.3892/etm.2022.11558
– ident: ref3
  doi: 10.1016/j.jpeds.2012.06.044
SSID ssj0069563
Score 2.3166614
Snippet Introduction: Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive...
Kasabach-Merritt phenomenon (KMP) is a rare and life-threatening disease, characterized by the profound thrombocytopenia and consumptive coagulopathy...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 174
SubjectTerms Case Series
Title Kasabach-Merritt Phenomenon: Diagnosis, Management, and Outcome on Two Cases in a Sub-Saharan Country (Senegal)
URI https://www.ncbi.nlm.nih.gov/pubmed/40438153
https://www.proquest.com/docview/3213608764
https://pubmed.ncbi.nlm.nih.gov/PMC12119071
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1662-6567
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069563
  issn: 1662-6567
  databaseCode: DOA
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1662-6567
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069563
  issn: 1662-6567
  databaseCode: M~E
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVKGR
  databaseName: Karger Open Access Journals
  customDbUrl:
  eissn: 1662-6567
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069563
  issn: 1662-6567
  databaseCode: M--
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.karger.com/OpenAccess
  providerName: Karger AG
– providerCode: PRVPQU
  databaseName: AUTh Library subscriptions: ProQuest Central
  customDbUrl:
  eissn: 1662-6567
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069563
  issn: 1662-6567
  databaseCode: BENPR
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health Medical collection
  customDbUrl:
  eissn: 1662-6567
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069563
  issn: 1662-6567
  databaseCode: 7X7
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLY6MwhxQeyUpTKIA6gTETuxE3ODmSJGQ0vF9NBb5SQOCYJ01KbDcOG_8c94trN04TAcuCSVU0eW35e32O99RuhFnEiVejFx4oBAgBJS3xHSd52UB0qb_4hGplD4YzAahdOpGHc6v-tamItvQVGEl5fi_L-KGtpA2Lp09h_E3bwUGuA3CB2uIHa4Xknwp3IpIxlnzlCTLpZlf5ypQvMs2CSOY5tbZ6kF2uSXOovz06qEQSm9hzD5Me8fgZEzGbNSqxjnTGp-58JUspcLkyhwBsryiz41QKz7ubpfsx9hEm61a7yxhH-cz83ZeKeZTPLvzaI04PWn6tcPhxLGMrG7-YW9bfc_gXg_y1vzMlRfbfX8SaE2FjUo0_sztlK60sOcUwdcTWuL1V_aauUd7IDUamJiD_-pjDqxx0Xt2gsmbIIl87lL3dYo1okAW7ayyWA0sRMTs6brHjqgARNasQ5_DWpngEP4aWo86rFX5FbQ9XXTddMl2olzttN11_yfyS10swpc8FsLuNuoo4o76PqwSs24i-bbuMMt7t7gBnWHuMXcIQbE4QpxeF5gQBw2iMN5gSVeQxyuEIdfVnh7dQ9N3g8mRx-c6jQPJ6bMg68_TcCYMLhFKU0TTiLGpPJlmkolZQJTwVMWgYZwFU-FK33wlDxNrpR6vgDP8j7ahwGrhwirJCIxT0KXJ9QXMRGEJVFMiAyEEjShXfS8ns_ZueVsme3Iq4ue1TM9A42qt8lkoear5cyjxOOaqdHvogd25pvX-IYSj3ldFG7IpPmDZmvffFLkmWFtN1yK4NA_usroHqMb7WfxBO2Xi5V6iq7FF2W-XPTQXjANzDXsoYN3g9H4c88sJvUM-P4ATua0aw
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kasabach-Merritt+Phenomenon%3A+Diagnosis%2C+Management%2C+and+Outcome+on+Two+Cases+in+a+Sub-Saharan+Country+%28Senegal%29&rft.jtitle=Case+reports+in+dermatology&rft.au=Diop%2C+Khadim&rft.au=Ndiaye+Diop%2C+Mame+T%C3%A9n%C3%A9&rft.au=Diop%2C+Ibrahima&rft.au=Mejri%2C+Ines&rft.date=2025-04-21&rft.issn=1662-6567&rft.eissn=1662-6567&rft.volume=17&rft.issue=1&rft.spage=174&rft.epage=180&rft_id=info:doi/10.1159%2F000546020&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000546020
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-6567&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-6567&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-6567&client=summon